Literature DB >> 1346373

Potent inhibition of aflatoxin-induced hepatic tumorigenesis by the monofunctional enzyme inducer 1,2-dithiole-3-thione.

T W Kensler1, J D Groopman, D L Eaton, T J Curphey, B D Roebuck.   

Abstract

1,2-Dithiole-3-thiones are five-membered cyclic sulfur-containing compounds with antioxidant, chemotherapeutic, radioprotective and chemoprotective properties. Several substituted 1,2-dithiole-3-thiones are used medicinally and one of these, oltipraz [5-(2-pyrazinyl)-4-methyl-1,2-dithiole-3-thione], has been recently shown to be an inhibitor of aflatoxin B1 (AFB1) hepatocarcinogenesis in the rat. Structure-activity studies have been undertaken to probe the mechanisms by which dithiolethiones inhibit carcinogenesis. Such studies revealed that unsubstituted 1,2-dithiole-3-thione was more effective than oltipraz at inhibiting aflatoxin-DNA adduct formation in vivo and at inducing electrophile detoxication enzymes in cell culture. In the present studies the effects of dietary administration of 1,2-dithiole-3-thione on the induction of xenobiotic metabolizing enzymes and inhibition of aflatoxin-induced hepatic tumorigenesis were examined. Male F344 rats were fed graded doses of 1,2-dithiole-3-thione (0.001-0.03%) for 4 weeks. During the second and third weeks of 1,2-dithiole-3-thione feeding, rats were dosed by gavage with 250 micrograms of AFB1/kg five times a week. Rats were then restored to control AIN-76A diet 1 week after cessation of AFB1 dosing. At 4 months, focal areas of hepatocellular alteration were identified and quantified by staining sections of liver for gamma-glutamyltranspeptidase (GGT) activity and glutathione S-transferase P (GST-P) expression. Treatment with 1,2-dithiole-3-thione at the lowest dose (0.001%) reduced by greater than 80% the volume of liver occupied by GGT or GST-P foci; higher dietary concentrations provided greater than 98% reductions in the volume per cent of these markers for presumptive preneoplastic lesions. All dietary concentrations of 1,2-dithiole-3-thione resulted in significant elevations in hepatic GST activities. In accord with the protective effects against tumorigenesis, 4- to 6-fold increases in the specific activities of aflatoxin-glutathione conjugation were observed in cytosols prepared from livers of animals fed 1,2-dithiole-3-thione. By contrast, 1,2-dithiole-3-thione did not have any detectable inductive effects on hepatic microsomal cytochrome P450 levels or activities. Dietary administration of 1,2-dithiole-3-thione also elevated activities of GSTs and other phase II enzymes in several extrahepatic organs. This broad pattern of induction of detoxication enzymes by 1,2-dithiole-3-thione supports the potential widespread use of this compound as a protective agent against chemical carcinogenesis and other forms of electrophile toxicity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1346373     DOI: 10.1093/carcin/13.1.95

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  11 in total

1.  Sulforaphane-mediated reduction of aflatoxin B₁-N⁷-guanine in rat liver DNA: impacts of strain and sex.

Authors:  Jeannette L A Fiala; Patricia A Egner; Nirachara Wiriyachan; Mathuros Ruchirawat; Kevin H Kensler; Gerald N Wogan; John D Groopman; Robert G Croy; John M Essigmann
Journal:  Toxicol Sci       Date:  2011-01-28       Impact factor: 4.849

2.  Lactone metabolite common to the carcinogens dioxane, diethylene glycol, and N-nitrosomorpholine: aqueous chemistry and failure to mediate liver carcinogenesis in the F344 rat.

Authors:  Niangoran Koissi; Niti H Shah; Brandon Ginevan; William S Eck; Bill D Roebuck; James C Fishbein
Journal:  Chem Res Toxicol       Date:  2012-04-12       Impact factor: 3.739

Review 3.  Dietary chemoprevention strategies for induction of phase II xenobiotic-metabolizing enzymes in lung carcinogenesis: A review.

Authors:  Xiang-Lin Tan; Simon D Spivack
Journal:  Lung Cancer       Date:  2009-01-31       Impact factor: 5.705

4.  Complete protection against aflatoxin B(1)-induced liver cancer with a triterpenoid: DNA adduct dosimetry, molecular signature, and genotoxicity threshold.

Authors:  Natalie M Johnson; Patricia A Egner; Victoria K Baxter; Michael B Sporn; Ryan S Wible; Thomas R Sutter; John D Groopman; Thomas W Kensler; Bill D Roebuck
Journal:  Cancer Prev Res (Phila)       Date:  2014-03-24

5.  Transgenic expression of aflatoxin aldehyde reductase (AKR7A1) modulates aflatoxin B1 metabolism but not hepatic carcinogenesis in the rat.

Authors:  Bill D Roebuck; Denise N Johnson; Carrie Hayes Sutter; Patricia A Egner; Peter F Scholl; Marlin D Friesen; Karen J Baumgartner; Nicholas M Ware; Sridevi Bodreddigari; John D Groopman; Thomas W Kensler; Thomas R Sutter
Journal:  Toxicol Sci       Date:  2009-01-23       Impact factor: 4.849

Review 6.  Dithiolethiones for cancer chemoprevention: where do we stand?

Authors:  Yuesheng Zhang; Rex Munday
Journal:  Mol Cancer Ther       Date:  2008-11       Impact factor: 6.261

7.  Anticancer activity and chemoprevention of xenobiotic organosulfurs in preclinical model systems.

Authors:  Robert E Click
Journal:  Oncol Discov       Date:  2013

8.  Aflatoxin-Exposure of Vibrio gazogenes as a Novel System for the Generation of Aflatoxin Synthesis Inhibitors.

Authors:  Phani M Gummadidala; Yung Pin Chen; Kevin R Beauchesne; Kristen P Miller; Chandrani Mitra; Nora Banaszek; Michelle Velez-Martinez; Peter D R Moeller; John L Ferry; Alan W Decho; Anindya Chanda
Journal:  Front Microbiol       Date:  2016-06-03       Impact factor: 5.640

9.  Decreased levels of 2-amino-3-methylimidazo[4,5-f]quinoline-DNA adducts in rats treated with beta-carotene, alpha-tocopherol and freeze-dried aloe.

Authors:  N Uehara; Y Iwahori; M Asamoto; H Baba-Toriyama; M Iigo; M Ochiai; M Nagao; M Nakayama; M Degawa; K Matsumoto; I Hirono; H Beppu; K Fujita; H Tsuda
Journal:  Jpn J Cancer Res       Date:  1996-04

Review 10.  Protective and Restorative Effects of Nutrients and Phytochemicals.

Authors:  Tania Rescigno; Mario F Tecce; Anna Capasso
Journal:  Open Biochem J       Date:  2018-04-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.